RIG-I usually refers to a virus-sensing protein made from the DDX58 gene. This gene plays an important role in helping your immune system detect viral material and turn on early antiviral defenses. If this system does not work well, you may be more prone to some infections. If it stays too active, it can lead to ongoing inflammation and may raise the chance of certain autoimmune conditions. Most variants have little effect, but a few can noticeably change immune signaling.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly control when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
RIGIGene function
What if the gene works
The DDX58 gene, often called RIG-I, makes a protein that helps cells detect viral RNA and start interferon signals. This supports an early immune response to many viral infections.
Risk
What if the gene does not work
Variants in the RIGI gene can range from milder to more severe. More disruptive changes may cause an inflammatory condition with dental, eye, skin, and artery changes, while others can weaken antiviral signaling and raise vulnerability to viral infections.
Treatment
What does that mean for your treatment
No RIGI-specific treatment or management approach is currently established for pathogenic or loss-of-function variants in the RIGI gene. RIG-I is being studied as a drug target in cancer and antiviral research, where drugs that activate this pathway may help strengthen immune responses.
Conditions associated with RIGI
Gene function
What if the gene works
Cells rely on the RIGI gene as part of the body’s first response to invading RNA viruses. It helps them spot unusual viral genetic material inside the cell and launch early immune signals. Understanding how the RIGI gene works can make it easier to see how your cells recognize RNA viruses early and organize a controlled response.
Cells use the RIGI gene to detect viral RNA in the fluid inside the cell. It is especially tuned to RNA patterns common in many viruses and uncommon in normal human RNA.
After sensing viral RNA, signals from the RIGI gene help switch on interferons (alarm proteins that warn nearby cells). It also supports other antiviral signals that prepare tissues to slow viral spread.
This gene helps cells tell likely viral RNA apart from most of the body’s own RNA. That makes the early immune response more focused on true infection signals.
Signals from this gene pass the message to partner proteins on mitochondria, the cell’s energy making structures. This relay helps coordinate the body’s fast first immune defense.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants influence the RIGI gene's function depends on whether a DNA change weakens the RIG-I protein made by the DDX58 gene or leaves it stuck in an "on" state. Milder variants may partly reduce protein stability, RNA binding, or the release of interferon (an antiviral alarm signal), while more severe loss-of-function variants can blunt this response more strongly. Other variants are gain-of-function changes that switch signaling on without the usual viral trigger, and stronger activating variants are linked to earlier or more marked inflammatory disease.
How variants are linked to conditions
When doctors look at how RIGI gene variants are linked to health conditions, the clearest established condition is Singleton-Merten syndrome type 2. A disease-causing variant in the RIGI gene can cause this rare inherited condition and can help confirm the diagnosis, especially when early dental problems, skin inflammation, bone or joint changes, or glaucoma are present. Some studies also connect the RIGI gene with differences in infection risk, but those findings are less settled and do not predict health outcomes on their own.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal feature of human biology. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences are involved. There are situations, though, where one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the RIGI gene. Anyone worried about personal or family risk can talk with a doctor or genetic counselor for guidance based on their own history.
Inheritance of RIGI variants
The RIGI gene inheritance pattern can differ depending on the condition and the specific variant. For some RIGI-related conditions, variants are inherited in an autosomal dominant way, which means one changed copy from either parent can be enough, and each child has a 50% chance of inheriting it; some cases also begin with a new variant that was not inherited from either parent. Other RIGI-related conditions follow an autosomal recessive pattern, so a child would need to inherit one changed copy from each parent. In practical terms, how RIGI gene variants are inherited depends on whether the variant acts in a dominant or recessive way in that family.
What does my RIGI result mean for my family?
For RIGI, what this means for family members depends on the condition linked to the specific result. Some well-known RIGI-related conditions can run in families in a dominant way, so close relatives may also carry the variant and may want to discuss testing. Other RIGI-related findings follow a recessive pattern, which means relatives may be healthy carriers without knowing it.
Genetic information
Genetic testing
How you find out about variants
Variants in the RIGI gene are found with genetic testing for RIGI gene variants, usually using a blood sample or saliva sample. A lab reads the DNA sequence and compares it with the usual code to see whether a variant is present. Results may show a known health related variant, a benign variant, or an uncertain finding.
When should I consider getting a genetic test?
Genetic testing for the RIGI gene may be worth considering if you or your child has signs of a rare inherited inflammatory condition, such as early loss of adult teeth, bone changes, or calcium buildup in the aorta, especially when similar problems run in the family. It can also help clarify some unusual immune-related illnesses.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, or respond to the same drug in different ways. These differences are common and can influence both how well a medicine helps and how sensitive someone is to it. Medication response is also shaped by age, other health conditions, and other medicines taken at the same time.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes influence how strongly a drug works or how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. If you want to learn more about this subject, additional information is available in the LearnHub.
Drugs influenced by the RIGI gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, treatment response, or your overall health, it makes sense to talk with your doctor.
History
The RIGI gene first entered the scientific literature in 1997, when researchers identified it as a gene switched on by retinoic acid during studies of leukemia cells. Its name came from that early finding: retinoic acid inducible gene I, often written as RIG-I. Building on this early work, scientists discovered in the early 2000s that it had a central place in the body’s first response to viral infection, which made it a major focus in immunology research. That shift changed how researchers understood antiviral defense and helped shape modern studies of influenza, hepatitis C, and other RNA viruses. Over time, the RIGI gene became one of the landmark genes in innate immunity research.